Guido Vanham

4.4k total citations
86 papers, 3.1k citations indexed

About

Guido Vanham is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Guido Vanham has authored 86 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Virology, 44 papers in Infectious Diseases and 26 papers in Immunology. Recurrent topics in Guido Vanham's work include HIV Research and Treatment (55 papers), HIV/AIDS Research and Interventions (26 papers) and HIV/AIDS drug development and treatment (25 papers). Guido Vanham is often cited by papers focused on HIV Research and Treatment (55 papers), HIV/AIDS Research and Interventions (26 papers) and HIV/AIDS drug development and treatment (25 papers). Guido Vanham collaborates with scholars based in Belgium, United States and United Kingdom. Guido Vanham's co-authors include Kevin K. Ariën, Kristien Verdonck, Elsa González, Eduardo Gotuzzo, Sonia Van Dooren, Anne–Mieke Vandamme, Eric J. Arts, Yven Van Herrewege, Johan Míchiels and Luc Kestens and has published in prestigious journals such as PLoS ONE, Biomaterials and Nature Reviews Microbiology.

In The Last Decade

Guido Vanham

86 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guido Vanham Belgium	30	1.2k	1.2k	1.1k	546	534	86	3.1k
Charlene S. Dezzutti United States	29	622 0.5×	1.2k 1.0×	1.4k 1.3×	697 1.3×	224 0.4×	106	2.8k
Donna L. Rudolph United States	25	1.2k 1.0×	586 0.5×	506 0.5×	355 0.7×	735 1.4×	68	2.8k
S. Michele Owen United States	33	560 0.5×	1.8k 1.5×	1.8k 1.6×	804 1.5×	740 1.4×	97	3.3k
Mary E. Klotman United States	48	2.1k 1.8×	2.1k 1.8×	2.3k 2.2×	1.6k 2.9×	1.9k 3.6×	131	7.3k
Carl V. Hanson United States	31	974 0.8×	1.2k 1.0×	871 0.8×	472 0.9×	785 1.5×	93	2.8k
Gilda Tachedjian Australia	37	600 0.5×	1.6k 1.4×	1.9k 1.8×	1.3k 2.4×	1.5k 2.8×	108	4.5k
Jan Weber Czechia	29	497 0.4×	1.0k 0.9×	1.0k 0.9×	494 0.9×	699 1.3×	119	3.0k
Maria Carla Re Italy	35	1.1k 0.9×	1.9k 1.6×	1.5k 1.4×	1.2k 2.1×	894 1.7×	258	4.6k
Steven Patterson United Kingdom	34	2.3k 2.0×	1.5k 1.3×	709 0.7×	787 1.4×	700 1.3×	122	4.2k
Simon M. Barratt‐Boyes United States	31	1.9k 1.6×	571 0.5×	933 0.9×	669 1.2×	700 1.3×	73	3.3k

Countries citing papers authored by Guido Vanham

Since Specialization

Citations

This map shows the geographic impact of Guido Vanham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Vanham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Vanham more than expected).

Fields of papers citing papers by Guido Vanham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guido Vanham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Vanham. The network helps show where Guido Vanham may publish in the future.

Co-authorship network of co-authors of Guido Vanham

This figure shows the co-authorship network connecting the top 25 collaborators of Guido Vanham. A scholar is included among the top collaborators of Guido Vanham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guido Vanham. Guido Vanham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gupta, Akshita, Elda Righi, Concetta Sciammarella, et al.. (2024). Interleukin‐2‐mediated CD4 T‐cell activation correlates highly with effective serological and T‐cell responses to SARS‐CoV‐2 vaccination in people living with HIV. Journal of Medical Virology. 96(8). e29820–e29820. 2 indexed citations

Jespers, Vicky, Jordan K. Kyongo, Sarah Joseph, et al.. (2017). A longitudinal analysis of the vaginal microbiota and vaginal immune mediators in women from sub-Saharan Africa. Scientific Reports. 7(1). 11974–11974. 98 indexed citations

Ariën, Kevin K., Françoise Baleux, Delphine Desjardins, et al.. (2016). CD4-mimetic sulfopeptide conjugates display sub-nanomolar anti-HIV-1 activity and protect macaques against a SHIV162P3 vaginal challenge. Scientific Reports. 6(1). 34829–34829. 8 indexed citations

Míchiels, Johan, et al.. (2016). Inhibition of HIV Virus by Neutralizing Vhh Attached to Dual Functional Liposomes Encapsulating Dapivirine. Nanoscale Research Letters. 11(1). 350–350. 19 indexed citations

Ariën, Kevin K., Johan Míchiels, Jurgen Joossens, et al.. (2016). Resistance and cross-resistance profile of the diaryltriazine NNRTI and candidate microbicide UAMC01398. Journal of Antimicrobial Chemotherapy. 71(5). 1159–1168. 5 indexed citations

Ariën, Kevin K., Johan Míchiels, Jurgen Joossens, et al.. (2013). Diaryltriazine non-nucleoside reverse transcriptase inhibitors are potent candidates for pre-exposure prophylaxis in the prevention of sexual HIV transmission. Journal of Antimicrobial Chemotherapy. 68(9). 2038–2047. 17 indexed citations

Bergh, Rafaël Van den, Sébastien Morin, Hans Jürgen Sass, et al.. (2012). Monocytes Contribute to Differential Immune Pressure on R5 versus X4 HIV through the Adipocytokine Visfatin/NAMPT. PLoS ONE. 7(4). e35074–e35074. 34 indexed citations

Lewi, Paul, Jan Heeres, Kevin K. Ariën, et al.. (2012). Reverse Transcriptase Inhibitors as Microbicides. Current HIV Research. 10(1). 27–35. 13 indexed citations

Vanham, Guido & Ellen Van Gulck. (2012). Can immunotherapy be useful as a “functional cure” for infection with Human Immunodeficiency Virus-1?. Retrovirology. 9(1). 72–72. 45 indexed citations

10.

Ariën, Kevin K., Jan Heeres, Jurgen Joossens, et al.. (2011). Novel diarylpyridinones, diarylpyridazinones and diarylphthalazinones as potential HIV-1 nonnucleoside reverse transcriptase inhibitors (NNRTIs). Bioorganic & Medicinal Chemistry. 19(20). 5924–5934. 15 indexed citations

11.

Huang, Chaobo, Stefaan J. Soenen, Ellen Van Gulck, et al.. (2011). Electrospun cellulose acetate phthalate fibers for semen induced anti-HIV vaginal drug delivery. Biomaterials. 33(3). 962–969. 123 indexed citations

12.

Bergh, Rafaël Van den, Éric Florence, Erika Vlieghe, et al.. (2010). Transcriptome analysis of monocyte-HIV interactions. Retrovirology. 7(1). 53–53. 45 indexed citations

13.

Gali, Youssef, Olivier Delézay, Joachim Brouwers, et al.. (2010). In Vitro Evaluation of Viability, Integrity, and Inflammation in Genital Epithelia upon Exposure to Pharmaceutical Excipients and Candidate Microbicides. Antimicrobial Agents and Chemotherapy. 54(12). 5105–5114. 56 indexed citations

14.

Gali, Youssef, Kevin K. Ariën, Marleen Praet, et al.. (2010). Development of an in vitro dual-chamber model of the female genital tract as a screening tool for epithelial toxicity. Journal of Virological Methods. 165(2). 186–197. 38 indexed citations

15.

Jallow, Sabelle, Tim Vincent, Aleksandra Leligdowicz, et al.. (2009). Presence of a Multidrug‐Resistance Mutation in an HIV‐2 Variant Infecting a Treatment‐Naive Individual in Caio, Guinea Bissau. Clinical Infectious Diseases. 48(12). 1790–1793. 6 indexed citations

16.

Verdonck, Kristien, Elsa González, Ward Schrooten, Guido Vanham, & Eduardo Gotuzzo. (2007). HTLV-1 infection is associated with a history of active tuberculosis among family members of HTLV-1-infected patients in Peru. Epidemiology and Infection. 136(8). 1076–1083. 24 indexed citations

17.

Steyaert, Sophia, Lieven Verhoye, Els Beirnaert, et al.. (2007). The intraspleen huPBL NOD/SCID model to study the human HIV-specific antibody response selected in the course of natural infection. Journal of Immunological Methods. 320(1-2). 49–57. 2 indexed citations

18.

Adaui, Vanessa, Kristien Verdonck, Iván Best, et al.. (2006). SYBR Green–based quantitation of human T-lymphotropic virus type 1 proviral load in Peruvian patients with neurological disease and asymptomatic carriers: Influence of clinical status, sex, and familial relatedness. Journal of NeuroVirology. 12(6). 456–465. 31 indexed citations

19.

Jallow, Sabelle, Steve Kaye, Abraham Alabi, et al.. (2006). Virological and immunological response to Combivir and emergence of drug resistance mutations in a cohort of HIV-2 patients in The Gambia. AIDS. 20(10). 1455–1458. 30 indexed citations

20.

Lardon, Filip, Zwi Berneman, Viggo Van Tendeloo, et al.. (1997). Generation of dendritic cells from bone marrow progenitors using GM‐CSF, TNF‐α, and additional cytokines: antagonistic effects of IL‐4 and IFN‐γ and selective involvement of TNF‐α receptor‐1. Immunology. 91(4). 553–559. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact